Tag: Prescription Drugs
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
Factors in therapeutic inertia examined in adults newly diagnosed with T2DM receiving primary care in the U.K.
Ticagrelor, Prasugrel Compared in ACS Treated With PCI
Prespecified subgroup analysis of data from a randomized clinical trial suggest that a prasugrel-based strategy is preferable
Use of Bronchodilators Down for Bronchiolitis Treatment in Infants
High hospital-level bronchodilator use not associated with better outcomes; adjustment follows AAP recommendations to limit routine use for bronchiolitis
HIV Incidence Remains Low With PrEP in Real-World Setting
Study of mainly gay or bisexual men shows low incidence of HIV, even when PrEP was mostly purchased rather than provided free
Drug May Curb ‘Sluggish’ Thinking in Some Adults With ADHD
Lisdexamfetamine found to reduce symptoms of sluggish cognitive tempo in small group of adults with ADHD
Oral Transglutaminase 2 Inhibitor Beneficial in Celiac Disease
ZED1227 attenuates gluten-induced duodenal mucosal damage among patients undergoing daily gluten challenge
Ovarian Stimulation Drugs Not Tied to Higher Breast Cancer Risk
Use of clomiphene citrate or gonadotropins, alone or in combination, not associated with increased risk for breast cancer
ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
ADA: Efpeglenatide Lowers Risk for Adverse CV Events in T2DM
Findings among patients with type 2 diabetes and history of cardiovascular disease or current kidney disease
Breast Cancer Prognosis No Better With Five Versus Two Years of Zoledronate
No significant difference found in disease-free survival, overall survival, distant disease-free survival for five versus two years of treatment
